Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
krt-232 (2 trials)
tl-895 (4 trials)
Hematologic Neoplasms (Phase 2)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Primary Myelofibrosis (Phase 2)
Trials (4 total)
Trial APIs (2 total)